Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jaroslav Pacovský is active.

Publication


Featured researches published by Jaroslav Pacovský.


BMC Urology | 2017

The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study

Miroslav Fajfr; Miroslav Louda; Pavla Paterová; Lenka Ryskova; Jaroslav Pacovský; Josef Košina; Helena Žemličková; Miloš Broďák

BackgroundAgainst a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic.MethodIn this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation.ResultsThe most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease.ConclusionWe have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase.


Urologie pro praxi | 2011

Extraperitoneální laparoskopická radikální prostatektomie

Miloš Broďák; Josef Košina; Jaroslav Všetička Ph.D; Lukáš Holub; Petr Hušek; Jaroslav Pacovský


Urologie pro praxi | 2010

Antibiotická profylaxe v urologii

Miloš Broďák; Josef Košina; Lukáš Holub; Pavel Navrátil; Miroslava Romžová; Miroslav Louda; Petr Kutílek Ph.D; Richard Fiala; Jaroslav Pacovský


Česká urologie | 2012

Oboustranná adrenalektomie - u pacientů s Cushingovým syndromem při ektopické sekreci ACTH

Petr Hušek; Jaroslav Pacovský; Filip Gabalec; Josef Košina; Jan Cap; Miloš Broďák


Urologie pro praxi | 2012

Radikální prostatektomie u pacientů s předoperačním PSA nad 20 ng/ml

Miloš Broďák; Josef Košina; Lukáš Holub; Pavel Navrátil; Miroslav Louda; Jaroslav Pacovský


Česká urologie | 2011

Výsledky léčby retroperitoneálních sarkomů a jejich hlavní rizika

Michal Balík; Zdeněk Zoul; Jiří Petera; Jaroslav Pacovský; Miloš Broďák


Urologie pro praxi | 2010

Emfyzematózní pyelonefritida - život ohrožující stav

Petr Hušek; Miloš Broďák; Jaroslav Pacovský


Urologie pro praxi | 2009

Současné chirurgické přístupy k léčbě varikokély

Ivo Novák Ph.D; Richard Fiala CSc; Jaroslav Pacovský; Miloslav Louda Ph.D; Peter Kuliaček; Libor Janeček; Antonín Krajina; Jan Raupach


Česká urologie | 2018

Dopady změny antimuskarinika na kvalitu života u pacientů s hyperaktivním měchýřem - výsledky studie VEST

Lukáš Holub; Petr Hušek; Josef Košina; Jaroslav Pacovský; Miloš Broďák


Česká urologie | 2017

Raritní histologický nález invazivního uroteliálního karcinomu močového měchýře

Jiří Špaček; Miroslav Louda; Miroslav Podhola; Jaroslav Pacovský; Miloš Broďák

Collaboration


Dive into the Jaroslav Pacovský's collaboration.

Top Co-Authors

Avatar

Miloš Broďák

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Josef Košina

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Miroslav Louda

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Pavel Navrátil

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

L. Holub

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Miroslav Podhola

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

P. Hušek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Milos Brodak

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Ivo Novák Ph.D

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Antonín Krajina

Charles University in Prague

View shared research outputs
Researchain Logo
Decentralizing Knowledge